Makuuchi, Rie
Terashima, Masanori
Terada, Mitsumi
Mizusawa, Junki
Kita, Ryosuke
Tokunaga, Masanori
Omori, Takeshi
Ojima, Toshiyasu
Ehara, Kazuhisa
Watanabe, Masaya
Yanagimoto, Yoshitomo
Nunobe, Souya
Kinoshita, Takahiro
Ito, Seiji
Nishida, Yasunori
Hihara, Jun
Boku, Narikazu
Kurokawa, Yukinori
Yoshikawa, Takaki
,
Funding for this research was provided by:
National Cancer Center Research and Development Fund (29-A-3, 2020-J-3, 2023-J-03, 29-A-3, 2020-J-3, 2023-J-03)
Japan Agency for Medical Research and Development (JP23ck0106844, JP23ck0106844)
Intuitive Surgical Sàrl
Article History
Received: 25 August 2023
Accepted: 5 October 2023
First Online: 17 October 2023
Declarations
:
: This study is being conducted according to the principles expressed in the Declaration of Helsinki, the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects, and the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines. The JCOG Protocol Review Committee approved this protocol in January 2020. Approval from the institutional review board was obtained before starting patient enrollment in each institution. Written informed consent has been obtained from all enrolled patients. At the time of submission (July 2022), 46 institutions were participating in this study. The participating institutions were as follows: Hakodate Goryoukaku Hospital, Keiyukai Sapporo Hospital, Miyagi Cancer Center, Fukushima Medical University Hospital, Southern Tohoku General Hospital, Saitama Prefectural Cancer Center, National Cancer Center Hospital East, Chiba Cancer Center, National Cancer Center Hospital, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo Medical and Dental University Hospital, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Toranomon Hospital, Juntendo University School of Medicine Juntendo Clinic, Kanagawa Cancer Center, Kitasato University School of Medicine, Toyama Prefectural Central Hospital, Ishikawa Prefectural Central Hospital, Yamanashi Prefectural Central Hospital, Gifu University School of Medicine, Shizuoka General Hospital, Shizuoka Cancer Center, Aichi Cancer Center, Nagoya University School of Medicine, National Hospital Organization Kyoto Medical Center, Osaka University Graduate School of Medicine, Osaka Metropolitan University Hospital, Osaka International Cancer Institute, National Hospital Organization Osaka National Hospital, Osaka Medical and Pharmaceutical University, Toyonaka Municipal Hospital, Kobe University Graduate School of Medicine, Kansai Rosai Hospital, Hyogo Cancer Center, Wakayama Medical University School of Medicine, Shimane University Faculty of Medicine, Okayama University Hospital, Hiroshima University Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City North Medical Center Asa Citizens Hospital, Kagawa Prefectural Central Hospital, National Hospital Organization Shikoku Cancer Center, and Kurume University Graduate School of Medicine.
: Not applicable.
: The authors declare no competing interests.